Arrested oocyst maturation in Plasmodium parasites lacking type II NADH:ubiquinone dehydrogenase.

Parasitology Unit, Max Planck Institute for Infection Biology, 10117 Berlin, Germany.
Journal of Biological Chemistry (Impact Factor: 4.6). 07/2011; 286(37):32661-71. DOI: 10.1074/jbc.M111.269399
Source: PubMed

ABSTRACT The Plasmodium mitochondrial electron transport chain has received considerable attention as a potential target for new antimalarial drugs. Atovaquone, a potent inhibitor of Plasmodium cytochrome bc(1), in combination with proguanil is recommended for chemoprophylaxis and treatment of malaria. The type II NADH:ubiquinone oxidoreductase (NDH2) is considered an attractive drug target, as its inhibition is thought to lead to the arrest of the mitochondrial electron transport chain and, as a consequence, pyrimidine biosynthesis, an essential pathway for the parasite. Using the rodent malaria parasite Plasmodium berghei as an in vivo infection model, we studied the role of NDH2 during Plasmodium life cycle progression. NDH2 can be deleted by targeted gene disruption and, thus, is dispensable for the pathogenic asexual blood stages, disproving the candidacy for an anti-malarial drug target. After transmission to the insect vector, NDH2-deficient ookinetes display an intact mitochondrial membrane potential. However, ndh2(-) parasites fail to develop into mature oocysts in the mosquito midgut. We propose that Plasmodium blood stage parasites rely on glycolysis as the main ATP generating process, whereas in the invertebrate vector, a glucose-deprived environment, the malaria parasite is dependent on an intact mitochondrial respiratory chain.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Malaria kills nearly one million people each year, and the protozoan parasite Plasmodium falciparum has become increasingly resistant to current therapies. Isoprenoid synthesis via the methylerythritol phosphate (MEP) pathway represents an attractive target for the development of new antimalarials. The phosphonic acid antibiotic fosmidomycin is a specific inhibitor of isoprenoid synthesis and has been a helpful tool to outline the essential functions of isoprenoid biosynthesis in P. falciparum. Isoprenoids are a large, diverse class of hydrocarbons that function in a variety of essential cellular processes in eukaryotes. In P. falciparum, isoprenoids are used for tRNA isopentenylation and protein prenylation, as well as synthesis of vitamin E, carotenoids, ubiquinone, and dolichols. Recently, isoprenoid synthesis in P. falciparum has been shown to be regulated by a sugar phosphatase. We outline what is known about isoprenoid function and regulation of isoprenoid synthesis in P. falciparum, in order to identify valuable directions for future research.
    Eukaryotic Cell 09/2014; · 3.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Leishmaniasis is a parasitic disease caused by the protozoan Leishmania, which is active in two broad forms namely, Visceral Leishmaniasis (VL or Kala Azar) and Cutaneous Leishmaniasis (CL). The disease is most prevalent in the tropical regions and poses a threat to over 70 countries across the globe. About 200 million people are estimated to be at risk of developing VL in the Indian subcontinent, and this refers to around 67% of the global VL disease burden. The Indian state of Bihar alone accounts for 50% of the total VL cases. While no vaccination exists, several pentavalent antimonials and drugs like Paromomycin, Amphotericin, Miltefosine etc. are used in the treatment of Leishmaniasis. However, due to their low efficacies and the resistance developed by the bug to these medications, there is an urgent need to look into newer species specific targets. The proteome information available suggests that among the 7960 proteins in Leishmania donavani, a staggering 65% remains classified as a hypothetical uncharacterized set. In this background, we have attempted to assign probable functions to these hypothetical sequences present in this parasite, to explore their plausible roles as druggable receptors. Thus, putative functions have been defined to 105 hypothetical proteins, which exhibited a GO term correlation and PFAM domain coverage of more than 50% over the query sequence length. Of these, 27 sequences were found to be associated with a reference pathway in KEGG as well. Further, using homology approaches, four pathways viz., Ubiquinone biosynthesis, Fatty acid elongation in Mitochondria, Fatty Acid Elongation in ER and Seleno-cysteine Metabolism have been reconstructed. In addition, 7 new putative essential genes have been mined with the help of Eukaryotic Database of Essential Genes (DEG). All these information related to pathways and essential genes indeed show promise for exploiting the select molecules as potential therapeutic targets.
    Frontiers in Genetics 08/2014; 5:291.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Metabolism is known for its intricate adjustments to meet the needs of an organism. Due to demands of adaptation, parasite metabolic pathways are greatly altered from those of their hosts. A key difference in metabolic pathways in Plasmodium spp, during the in-tra-erythrocytic stages, pertains to energy metabolism with the absence of a major role for the mitochondria in adenosine triphosphate (ATP) generation. In most organisms there exists a tight link between nucleotide and energy metabolism. An important feature of purine nucleotide metabolism in Plasmodium falcipa-rum is the absence of the de novo pathway, with purine requirements being completely met by the sal-vage pathway. Presence of the enzymes adenylosucci-nate lyase, adenylosuccinate synthetase and adenosine monophosphate (AMP) deaminase, involved in AMP metabolism, suggests the existence of a functional purine nucleotide cycle (PNC) in P. falciparum with fumarate, a tricarboxylic acid (TCA) cycle intermedi-ate, and ammonia being the net output from the cycle. In the absence of a conventional TCA cycle, the fate of fumarate generated from PNC merits examination. In this review we cover ATP generation through glycoly-sis, key features of the TCA cycle, the role of electron transport chain and the link between PNC and the mitochondrion. Recent studies using genetic appro-aches highlight unexpected features that were hitherto unknown with respect to these pathways and these are also summarized in this review.
    Current science 10/2012; · 0.83 Impact Factor


Available from
May 31, 2014